Guardant Health (GH) Sell-Off Makes Neogenomics (NEO) Deal Less Likely - Needham & Company
- Nasdaq, S&P tumble as Netflix, chip stocks drag; AmEx boosts Dow
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Nasdaq tumbles, Treasuries dip amid earnings, geopolitical crosscurrents
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Jabil falls after placing CEO on paid leave amid internal investigation
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
Guardant Health (GH) Said to Decide Against NeoGenomics (NEO) Takeover - Bloomberg
October 4, 2021 6:16 AM EDTGuardant Health (NASDAQ: GH) had decided not to pursue a potential acquisition of NeoGenomics (NASDAQ: NEO), according to Bloomberg, citing people familiar with the matter. It decided against the deal over the weekend.
Shares in Guardant have fallen nearly 20% since talks began.
... MoreGuardant Health's (GH) Potential Deal for NeoGenomics (NEO) Would Be Dilutive to Top Line - Stifel
October 1, 2021 12:57 PM EDTStifel analyst Daniel Arias weighs in on speculation Guardant Health (NASDAQ: GH) is looking to acquire NeoGenomics (NASDAQ: NEO).
Arias said the deal would be dilutive to GH's top-line. He commented: "... we have GH growing 40% in... More
Increasing unusual option volume: IRNT PROG AEZS AVIR NEO OPAD
October 1, 2021 10:12 AM EDTIncreasing unusual option volume: IRNT PROG AEZS AVIR NEO OPAD
... MoreIncreasing unusual option volume: IRNT PROG AEZS AVIR NEO OPAD
October 1, 2021 10:01 AM EDTIncreasing unusual option volume: IRNT PROG AEZS AVIR NEO OPAD
... MorePre-Open Stock Movers 10/01: (NEO) (SPWR) (MRK) Higher; (OMER) (IRNT) Lower (more...)
October 1, 2021 9:27 AM EDTPre-Open Stock Movers:
Omeros Corporation (Nasdaq: OMER) 30% LOWER; announced that the U.S. Food and Drug Administration (FDA) notified the company that, as part of FDAs ongoing review of the companys Biologics License Application (BLA) for narsoplimab in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA), FDA has identified deficiencies that preclude discussion of labeling and post-marketing requirements/commitments at this time. FDA stated that the notification does not reflect a final decision on the information under review.
IronNet (NYSE:... More
Guardant Health (GH) Said to Weigh Takeover of NeoGenomics (NEO) - Bloomberg
October 1, 2021 9:03 AM EDT(Updated - October 1, 2021 9:05 AM EDT)
Guardant Health (NASDAQ: GH) is exploring an acquisition of NeoGenomics (NASDAQ: NEO), according to Bloomberg, citing people familiar with the matter.
The companies have held talks about a potential deal, and deliberations are ongoing.
... More